Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-06-12
1999-10-12
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540488, 540490, 540547, 540548, 540552, A61K 3155, C07D26708, C07D28108
Patent
active
059655534
ABSTRACT:
This invention relates to certain benzoxazepinones and benzothiazepinones useful as hypocholesterolemic agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, Alzheimer's agents or anti-acne agents.
REFERENCES:
patent: 5488149 (1996-01-01), Nomoto et al.
patent: 5698691 (1997-12-01), Yukimasa et al.
patent: 5726306 (1998-03-01), Yukimasa et al.
patent: 5753649 (1998-05-01), Tahara et al.
patent: 5770438 (1998-06-01), Nakahama et al.
patent: 5770594 (1998-06-01), Hamanaka et al.
Squalene Synthetase inhibitors, Current Opinion in Therapetic Patents, 1993, pp. 861-864.
Bell Andrew S.
Hamanaka Ernest S.
Hayward Cheryl M.
Scully Douglas A.
Stammen Blanda
Benson Gregg C.
Coleman Brenda
Olson A. Dean
Pfizer Inc.
Richardson Peter C.
LandOfFree
Squalene synthetase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Squalene synthetase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Squalene synthetase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652635